Klotho Neurosciences, Inc. KLTO
Set alert
As of Mar 16, 3:59 PM ET
- YTD
- +31.83%
- 1 year
- +34.72%
- Open
- 0.406
- Prev close
- 0.381
- Mkt cap
- 20.08M
- Vol
- 95.00K
- Avg vol
- 8.09M
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.37
- High
- 0.41
- Forward P/E
- 0.00
- Beta
- 0.06
- Short ratio
- 0.34
- Inst. own
- 11.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.45094
- 200-d avg
- 3.47
- 1y target
- 0.00
Key statistics
- Market cap
- 9.86M
- Enterprise value
- 10.29M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 424.00
- EPS (TTM)
- 0.00
- Beta
- 0.06
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -168.17K
- Total cash
- 845.34K
- Total debt
- 3.90M
- Return on equity
- 0.00%
- Shares outstanding
- 23.26M
- Short % of float
- 0.00%
- 50-day average
- 0.45094
- 200-day average
- 3.47
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- klothoneuro.com
News
- Klotho Neurosciences (NASDAQ:KLTO) and Xenetic Biosciences (NASDAQ:XBIO) Head to Head Contrast
- Citius Pharmaceuticals (NASDAQ:CTXR) and Klotho Neurosciences (NASDAQ:KLTO) Head-To-Head Comparison
- Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML
- Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML Effective March 12, 2026
- KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR
- 12 Health Care Stocks Moving In Friday's After-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
- 12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on KLTO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHARDAN MONTEREY INVESTMENTS LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 1, 2024 | 1,284,360 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Meteora Capital, LLC | 2.51% | 533,951 | 226.40K | Sep 29, 2024 |
| Morgan Stanley | 0.47% | 100,000 | 42.40K | Sep 29, 2024 |
| MMCAP International, Inc. SPC | 0.38% | 80,000 | 33.92K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.30% | 63,234 | 26.81K | Sep 29, 2024 |
| UBS Group AG | 0.07% | 15,306 | 6.49K | Sep 29, 2024 |
| Gabelli & Co. Investment Advisers, Inc. | 0.05% | 10,000 | 4.24K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.23% | 47,923 | 20.32K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 14,768 | 6.26K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 12,306 | 5.22K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 3,048 | 1.29K | Oct 30, 2024 |